These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 176400)

  • 1. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
    Boyle MD; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
    Rella W; Chaput B
    Oncology; 1978; 35(3):136-42. PubMed ID: 209379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG).
    Zwilling BS; Leonard EJ; Bast RC; Zbar B
    J Natl Cancer Inst; 1974 Aug; 53(2):541-6. PubMed ID: 4367248
    [No Abstract]   [Full Text] [Related]  

  • 6. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
    Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
    Osteen RT; Piessens WF; David JR; Churchill WH
    J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors.
    Borsos T; Richardson AK; Ohanian SH; Leonard EJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1955-60. PubMed ID: 4128823
    [No Abstract]   [Full Text] [Related]  

  • 9. Humoral immune responses to tumor-specific antigens in strain-2 guinea pigs.
    Smith HG; Leonard EJ
    J Natl Cancer Inst; 1974 Jul; 53(1):187-94. PubMed ID: 4366195
    [No Abstract]   [Full Text] [Related]  

  • 10. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 11. Guinea pig tumor-specific natural antibodies in normal rabbit sera.
    Borsos T; Oanian SH
    J Natl Cancer Inst; 1974 Dec; 53(6):1827-9. PubMed ID: 4436873
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    Bucana C; Hanna MG
    J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of tumor growth in strain 2 guinea pigs by xenogeneic antitumor antibody.
    Smith HG; Meltzer MS; Leonard EJ
    J Natl Cancer Inst; 1976 Oct; 57(4):809-13. PubMed ID: 187778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertical transmission of tumour resistance in guinea pigs.
    Wainberg MA; Minden P; Weiss DW
    Nature; 1976 Jan; 259(5540):213-5. PubMed ID: 175279
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
    Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
    Wainberg MA; Deutsch V; Weiss DW
    Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.